Prof. Dr. Barbara Rothen-Rutishauser has received her doctorate in cell biology from the Swiss Federal Institute of Technology (ETH) in Zurich in 1996. From 1996 to 2000 she was a postdoctoral fellow in Biopharmacy at the Institute of Pharmaceutical Sciences, ETHZ, and in 2000 she joined Prof. Peter Gehr’s research group at the University of Bern, Switzerland as a postdoc. After being promoted to group leader in 2006 she completed her habilitation in cell biology in 2009. B. Rothen-Rutishauser is an expert in the field of cell-nanomaterial interactions in the lung, with a particular focus on 3D tissue models, e.g. lung, and nanomaterial aerosol exposures. Since 2011 she is the new chair in BioNanomaterials at the Adolphe Merkle Institute, University of Fribourg, Switzerland, the position is shared equally with Prof. Alke Fink. The activities of the research group cover many areas, from material synthesis and characterization to biological responses and hazard assessment. Prof. Rothen-Rutishauser has published more than 250 peer-reviewed papers and is an associate editor of the journal “Particle and Fibre Toxicology”.